カテゴリー： QYResearch, 世界, 医療/バイオ

世界の整形外科用再生外科製品市場インサイト及び予測（同種移植片、合成、細胞系、ビスコサプリメント）

◆英語タイトル：Global Orthopedic Regenerative Surgical Products Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX09926）◆商品コード：QY22JLX09926
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：109
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、整形外科用再生外科製品のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に整形外科用再生外科製品の世界市場のxxx％を占める「同種移植片」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「整形外科痛み管理」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
整形外科用再生外科製品の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの整形外科用再生外科製品市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

整形外科用再生外科製品のグローバル主要企業には、Anika Therapeutics、Vericel Corporation、Baxter、Zimmer Biomet、Stryker、Smith & Nephew、AlloSource、Amniox Medical、VSY Biotechnology、Aptissen、MiMedxなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

整形外科用再生外科製品市場は、種類と用途によって区分されます。世界の整形外科用再生外科製品市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
同種移植片、合成、細胞系、ビスコサプリメント

【用途別セグメント】
整形外科痛み管理、外傷修復、軟骨＆腱修復、関節再建、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 整形外科用再生外科製品製品概要
- 種類別市場（同種移植片、合成、細胞系、ビスコサプリメント）
- 用途別市場（整形外科痛み管理、外傷修復、軟骨＆腱修復、関節再建、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の整形外科用再生外科製品販売量予測2017-2028
- 世界の整形外科用再生外科製品売上予測2017-2028
- 整形外科用再生外科製品の地域別販売量
- 整形外科用再生外科製品の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別整形外科用再生外科製品販売量
- 主要メーカー別整形外科用再生外科製品売上
- 主要メーカー別整形外科用再生外科製品価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（同種移植片、合成、細胞系、ビスコサプリメント）
- 整形外科用再生外科製品の種類別販売量
- 整形外科用再生外科製品の種類別売上
- 整形外科用再生外科製品の種類別価格
・用途別市場規模（整形外科痛み管理、外傷修復、軟骨＆腱修復、関節再建、その他）
- 整形外科用再生外科製品の用途別販売量
- 整形外科用再生外科製品の用途別売上
- 整形外科用再生外科製品の用途別価格
・北米市場
- 北米の整形外科用再生外科製品市場規模（種類別、用途別）
- 主要国別の整形外科用再生外科製品市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの整形外科用再生外科製品市場規模（種類別、用途別）
- 主要国別の整形外科用再生外科製品市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の整形外科用再生外科製品市場規模（種類別、用途別）
- 主要国別の整形外科用再生外科製品市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の整形外科用再生外科製品市場規模（種類別、用途別）
- 主要国別の整形外科用再生外科製品市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの整形外科用再生外科製品市場規模（種類別、用途別）
- 主要国別の整形外科用再生外科製品市場規模（トルコ、サウジアラビア）
・企業情報
Anika Therapeutics、Vericel Corporation、Baxter、Zimmer Biomet、Stryker、Smith & Nephew、AlloSource、Amniox Medical、VSY Biotechnology、Aptissen、MiMedx
・産業チェーン及び販売チャネル分析
- 整形外科用再生外科製品の産業チェーン分析
- 整形外科用再生外科製品の原材料
- 整形外科用再生外科製品の生産プロセス
- 整形外科用再生外科製品の販売及びマーケティング
- 整形外科用再生外科製品の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 整形外科用再生外科製品の産業動向
- 整形外科用再生外科製品のマーケットドライバー
- 整形外科用再生外科製品の課題
- 整形外科用再生外科製品の阻害要因
・主な調査結果

Regenerative orthopedics may improve pain and discomfort of the musculoskeletal system and enhance the healing of orthopedic conditions, such as injuries of a tendon, ligament, bone, muscle, spinal disc, meniscus of the knee, cartilage or other musculoskeletal tissue. Growing technological advancements, the prevalence of arthritis and other orthopedic conditions, orthopedic surgeries, and R&D activities are some of the key drivers of this market.
Market Analysis and Insights: Global Orthopedic Regenerative Surgical Products Market
The global Orthopedic Regenerative Surgical Products market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Allografts accounting for % of the Orthopedic Regenerative Surgical Products global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Orthopedic Pain Management segment is altered to an % CAGR throughout this forecast period.
China Orthopedic Regenerative Surgical Products market size is valued at US$ million in 2021, while the North America and Europe Orthopedic Regenerative Surgical Products are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Orthopedic Regenerative Surgical Products landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Orthopedic Regenerative Surgical Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Orthopedic Regenerative Surgical Products market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Orthopedic Regenerative Surgical Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Orthopedic Regenerative Surgical Products market.
Global Orthopedic Regenerative Surgical Products Scope and Market Size
Orthopedic Regenerative Surgical Products market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Orthopedic Regenerative Surgical Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Allografts
Synthetic
Cell-based
Viscosupplements
Segment by Application
Orthopedic Pain Management
Trauma Repair
Cartilage & tendon repair
Joint reconstruction
Others
By Company
Anika Therapeutics
Vericel Corporation
Baxter
Zimmer Biomet
Stryker
Smith & Nephew
AlloSource
Amniox Medical
VSY Biotechnology
Aptissen
MiMedx
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orthopedic Regenerative Surgical Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Allografts
1.2.3 Synthetic
1.2.4 Cell-based
1.2.5 Viscosupplements
1.3 Market by Application
1.3.1 Global Orthopedic Regenerative Surgical Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Orthopedic Pain Management
1.3.3 Trauma Repair
1.3.4 Cartilage & tendon repair
1.3.5 Joint reconstruction
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Orthopedic Regenerative Surgical Products Market Perspective (2017-2028)
2.2 Orthopedic Regenerative Surgical Products Growth Trends by Region
2.2.1 Orthopedic Regenerative Surgical Products Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Orthopedic Regenerative Surgical Products Historic Market Size by Region (2017-2022)
2.2.3 Orthopedic Regenerative Surgical Products Forecasted Market Size by Region (2023-2028)
2.3 Orthopedic Regenerative Surgical Products Market Dynamics
2.3.1 Orthopedic Regenerative Surgical Products Industry Trends
2.3.2 Orthopedic Regenerative Surgical Products Market Drivers
2.3.3 Orthopedic Regenerative Surgical Products Market Challenges
2.3.4 Orthopedic Regenerative Surgical Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Orthopedic Regenerative Surgical Products Players by Revenue
3.1.1 Global Top Orthopedic Regenerative Surgical Products Players by Revenue (2017-2022)
3.1.2 Global Orthopedic Regenerative Surgical Products Revenue Market Share by Players (2017-2022)
3.2 Global Orthopedic Regenerative Surgical Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Orthopedic Regenerative Surgical Products Revenue
3.4 Global Orthopedic Regenerative Surgical Products Market Concentration Ratio
3.4.1 Global Orthopedic Regenerative Surgical Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orthopedic Regenerative Surgical Products Revenue in 2021
3.5 Orthopedic Regenerative Surgical Products Key Players Head office and Area Served
3.6 Key Players Orthopedic Regenerative Surgical Products Product Solution and Service
3.7 Date of Enter into Orthopedic Regenerative Surgical Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Orthopedic Regenerative Surgical Products Breakdown Data by Type
4.1 Global Orthopedic Regenerative Surgical Products Historic Market Size by Type (2017-2022)
4.2 Global Orthopedic Regenerative Surgical Products Forecasted Market Size by Type (2023-2028)
5 Orthopedic Regenerative Surgical Products Breakdown Data by Application
5.1 Global Orthopedic Regenerative Surgical Products Historic Market Size by Application (2017-2022)
5.2 Global Orthopedic Regenerative Surgical Products Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Orthopedic Regenerative Surgical Products Market Size (2017-2028)
6.2 North America Orthopedic Regenerative Surgical Products Market Size by Type
6.2.1 North America Orthopedic Regenerative Surgical Products Market Size by Type (2017-2022)
6.2.2 North America Orthopedic Regenerative Surgical Products Market Size by Type (2023-2028)
6.2.3 North America Orthopedic Regenerative Surgical Products Market Share by Type (2017-2028)
6.3 North America Orthopedic Regenerative Surgical Products Market Size by Application
6.3.1 North America Orthopedic Regenerative Surgical Products Market Size by Application (2017-2022)
6.3.2 North America Orthopedic Regenerative Surgical Products Market Size by Application (2023-2028)
6.3.3 North America Orthopedic Regenerative Surgical Products Market Share by Application (2017-2028)
6.4 North America Orthopedic Regenerative Surgical Products Market Size by Country
6.4.1 North America Orthopedic Regenerative Surgical Products Market Size by Country (2017-2022)
6.4.2 North America Orthopedic Regenerative Surgical Products Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Orthopedic Regenerative Surgical Products Market Size (2017-2028)
7.2 Europe Orthopedic Regenerative Surgical Products Market Size by Type
7.2.1 Europe Orthopedic Regenerative Surgical Products Market Size by Type (2017-2022)
7.2.2 Europe Orthopedic Regenerative Surgical Products Market Size by Type (2023-2028)
7.2.3 Europe Orthopedic Regenerative Surgical Products Market Share by Type (2017-2028)
7.3 Europe Orthopedic Regenerative Surgical Products Market Size by Application
7.3.1 Europe Orthopedic Regenerative Surgical Products Market Size by Application (2017-2022)
7.3.2 Europe Orthopedic Regenerative Surgical Products Market Size by Application (2023-2028)
7.3.3 Europe Orthopedic Regenerative Surgical Products Market Share by Application (2017-2028)
7.4 Europe Orthopedic Regenerative Surgical Products Market Size by Country
7.4.1 Europe Orthopedic Regenerative Surgical Products Market Size by Country (2017-2022)
7.4.2 Europe Orthopedic Regenerative Surgical Products Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Orthopedic Regenerative Surgical Products Market Size (2017-2028)
8.2 Asia-Pacific Orthopedic Regenerative Surgical Products Market Size by Type
8.2.1 Asia-Pacific Orthopedic Regenerative Surgical Products Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Orthopedic Regenerative Surgical Products Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Orthopedic Regenerative Surgical Products Market Share by Type (2017-2028)
8.3 Asia-Pacific Orthopedic Regenerative Surgical Products Market Size by Application
8.3.1 Asia-Pacific Orthopedic Regenerative Surgical Products Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Orthopedic Regenerative Surgical Products Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Orthopedic Regenerative Surgical Products Market Share by Application (2017-2028)
8.4 Asia-Pacific Orthopedic Regenerative Surgical Products Market Size by Region
8.4.1 Asia-Pacific Orthopedic Regenerative Surgical Products Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Orthopedic Regenerative Surgical Products Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Orthopedic Regenerative Surgical Products Market Size (2017-2028)
9.2 Latin America Orthopedic Regenerative Surgical Products Market Size by Type
9.2.1 Latin America Orthopedic Regenerative Surgical Products Market Size by Type (2017-2022)
9.2.2 Latin America Orthopedic Regenerative Surgical Products Market Size by Type (2023-2028)
9.2.3 Latin America Orthopedic Regenerative Surgical Products Market Share by Type (2017-2028)
9.3 Latin America Orthopedic Regenerative Surgical Products Market Size by Application
9.3.1 Latin America Orthopedic Regenerative Surgical Products Market Size by Application (2017-2022)
9.3.2 Latin America Orthopedic Regenerative Surgical Products Market Size by Application (2023-2028)
9.3.3 Latin America Orthopedic Regenerative Surgical Products Market Share by Application (2017-2028)
9.4 Latin America Orthopedic Regenerative Surgical Products Market Size by Country
9.4.1 Latin America Orthopedic Regenerative Surgical Products Market Size by Country (2017-2022)
9.4.2 Latin America Orthopedic Regenerative Surgical Products Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Orthopedic Regenerative Surgical Products Market Size (2017-2028)
10.2 Middle East & Africa Orthopedic Regenerative Surgical Products Market Size by Type
10.2.1 Middle East & Africa Orthopedic Regenerative Surgical Products Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Orthopedic Regenerative Surgical Products Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Orthopedic Regenerative Surgical Products Market Share by Type (2017-2028)
10.3 Middle East & Africa Orthopedic Regenerative Surgical Products Market Size by Application
10.3.1 Middle East & Africa Orthopedic Regenerative Surgical Products Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Orthopedic Regenerative Surgical Products Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Orthopedic Regenerative Surgical Products Market Share by Application (2017-2028)
10.4 Middle East & Africa Orthopedic Regenerative Surgical Products Market Size by Country
10.4.1 Middle East & Africa Orthopedic Regenerative Surgical Products Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Orthopedic Regenerative Surgical Products Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Anika Therapeutics
11.1.1 Anika Therapeutics Company Details
11.1.2 Anika Therapeutics Business Overview
11.1.3 Anika Therapeutics Orthopedic Regenerative Surgical Products Introduction
11.1.4 Anika Therapeutics Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.1.5 Anika Therapeutics Recent Developments
11.2 Vericel Corporation
11.2.1 Vericel Corporation Company Details
11.2.2 Vericel Corporation Business Overview
11.2.3 Vericel Corporation Orthopedic Regenerative Surgical Products Introduction
11.2.4 Vericel Corporation Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.2.5 Vericel Corporation Recent Developments
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Orthopedic Regenerative Surgical Products Introduction
11.3.4 Baxter Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.3.5 Baxter Recent Developments
11.4 Zimmer Biomet
11.4.1 Zimmer Biomet Company Details
11.4.2 Zimmer Biomet Business Overview
11.4.3 Zimmer Biomet Orthopedic Regenerative Surgical Products Introduction
11.4.4 Zimmer Biomet Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.4.5 Zimmer Biomet Recent Developments
11.5 Stryker
11.5.1 Stryker Company Details
11.5.2 Stryker Business Overview
11.5.3 Stryker Orthopedic Regenerative Surgical Products Introduction
11.5.4 Stryker Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.5.5 Stryker Recent Developments
11.6 Smith & Nephew
11.6.1 Smith & Nephew Company Details
11.6.2 Smith & Nephew Business Overview
11.6.3 Smith & Nephew Orthopedic Regenerative Surgical Products Introduction
11.6.4 Smith & Nephew Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.6.5 Smith & Nephew Recent Developments
11.7 AlloSource
11.7.1 AlloSource Company Details
11.7.2 AlloSource Business Overview
11.7.3 AlloSource Orthopedic Regenerative Surgical Products Introduction
11.7.4 AlloSource Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.7.5 AlloSource Recent Developments
11.8 Amniox Medical
11.8.1 Amniox Medical Company Details
11.8.2 Amniox Medical Business Overview
11.8.3 Amniox Medical Orthopedic Regenerative Surgical Products Introduction
11.8.4 Amniox Medical Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.8.5 Amniox Medical Recent Developments
11.9 VSY Biotechnology
11.9.1 VSY Biotechnology Company Details
11.9.2 VSY Biotechnology Business Overview
11.9.3 VSY Biotechnology Orthopedic Regenerative Surgical Products Introduction
11.9.4 VSY Biotechnology Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.9.5 VSY Biotechnology Recent Developments
11.10 Aptissen
11.10.1 Aptissen Company Details
11.10.2 Aptissen Business Overview
11.10.3 Aptissen Orthopedic Regenerative Surgical Products Introduction
11.10.4 Aptissen Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.10.5 Aptissen Recent Developments
11.11 MiMedx
11.11.1 MiMedx Company Details
11.11.2 MiMedx Business Overview
11.11.3 MiMedx Orthopedic Regenerative Surgical Products Introduction
11.11.4 MiMedx Revenue in Orthopedic Regenerative Surgical Products Business (2017-2022)
11.11.5 MiMedx Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の整形外科用再生外科製品市場インサイト及び予測（同種移植片、合成、細胞系、ビスコサプリメント）(Global Orthopedic Regenerative Surgical Products Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 骨&関節における再生医療のグローバル市場展望 2023年-2029年：同種骨治療、自家骨治療、移植骨代替療法、整形外科&関節疾患治療
  • 整形外科用パンチのグローバル市場予測2023-2029
  • 世界の整形外科外科用動力工具市場インサイト及び予測（電動、空気圧式）
  • 世界の多機能整形外科ロボット市場インサイト及び予測（セミアクティブ、アクティブ、パッシブ）
  • 世界の股関節＆膝整形外科用インプラント市場2022年：セラミックインプラント、金属インプラント、ポリマーインプラント